There is currently no evidence to support restricting the use of the AstraZeneca Covid-19 vaccine to certain age groups, the European Medicines Agency said on Wednesday after Germany joined several countries in limiting its use to older people. “According to the current scientific knowledge, there is no evidence that would support restricting the use of this vaccine in any population,” EMA chief Emer Cooke said, following a review of evidence by the agency. The EMA has received reports of 44 rare blood clotting cases among 9.2 million people who received the vaccine across the European Economic Area. Norway and Denmark have not yet resumed administering the vaccines, pending further evidence. No cases of blood clotting similar to those in Germany have been reported in Ireland, it confirmed.

Source: The Irish Times March 31, 2021 16:22 UTC